Sorbonne University
France
ICM University of Warsaw
Poland
Charles University
Czech Republic
© 2023 ICM UW. The site uses stock photos and photos that are intellectual property of 4EU+ universities. All photography is for illustrative purposes only.
Ahmed Idbaih is profesor of neurology at Sorbonne University, attending neuro-oncologist at AP-HP/La Pitié-Salpêtrière université hospital and researcher at the Paris Brain Institute. He obtained his MD with a specialization in neurology/neuro-oncology at Sorbonne University. Alongside his medical studies, he completed a PhD in molecular oncology at the Institute Curie in Paris, then completed his biology training with a post-doctoral fellowship at the Dana Farber Cancer Institute in Boston. Ahmed Idbaih takes care of malignant primary brain tumor patients in the department of neuro-oncology of the AP-HP/La Pitié-Salpêtrière University hospital. He has a strong interest in clinical and preclinical research. He is principal investigator or co-investigator of several clinical trials dedicated to glioma patients.
He is also the chair of the Domain 10 (primary brain tumors) of the European Reference Network EURACAN dedicated to rare solid cancers in adults. His laboratory research is focused on experimental therapeutics. He is the principal investigator of the research group glioblastoma and experimental therapeutics (GLIOTEX) focused on development of relevant preclinical models of glioblastoma and on investigating innovative therapeutic strategies in these models toward translation to glioblastoma patients in the setting of early phase clinical trials.
Ahmed Idbaih is the chair of teaching department of neurology at Sorbonne University and the co-chair of the 4EU+ against cancer program.
He is member of the brain tumor group of the European Organisation for. Research and Treatment of Cancer, the European Association of Neurology, the European Association of Neuro-Oncology and the French society of neurology. He is the vice-president of the French-speaking association of neuro-oncology. Ahmed Idbaih has published more than 250 peer-reviewed papers.
Catherine Suski-Grabowski, PhD, has an extensive experience in genomic analyses; she graduated from the Paris-Saclay University, Department of Molecular Genetics, where she defended her doctoral dissertation on DNA replication. Between 2003-2010, she conducted research at the Sloan Kettering Institute Cancer Centre in New York and the Weatherall Institute of Molecular Medicine Cancer Research Oxford University, on DNA structural blockages, using biochemical and molecular methods combine to bioinformatic analysis. In 2011-2017, Suski-Grabowski led a research group at the Institute of Biochemistry and Biophysics, Polish Academy of Sciences. Thanks to the grants received from the NCN and FNP agencies, together with a team of doctoral and graduate students, she studied the impact of DNA-polymerase damage on DNA replication using sequencing and analysing the results in silico. Since 2018, she leads the OMICS Data Science Group at the University of Warsaw, where she is currently the head of post-graduated program: Omics Data Science -Bioinformatics and Analysis of Large-Scale Biomedical Data, the 4EU + program coordinator: Comprehensive and integrative educational program in oncology and studies the post COVID disease: multisystem inflammatory syndrome in children.
Professor Aleksi Šedo, M.D., PhD. D.Sc. has an extensive experience in medicine and medical research, e.g. medical chemistry and pathobiochemistry and experimental oncology. He graduated as M.D. from the Charles University in Prague, where he also defended his Ph.D. and D.Sc. grades.
During his academic career he served a Member of the expert group of Czech Parliament subcommittee for Science and Universities, Member of Scientific Board of Ministry of Health of Czech Republic and Head-founder of Czech Association of Deans of Medical Faculties. He spent four years in academic and industrial research positions in several countries (visiting professor at the Institute of Mutagenesis and Differentiation, CNR, Italy, senior scientist in R&D Procter and Gamble, Germany, research fellow in Institute Curie, France).
For 12 years he was the Head of the Joint Laboratory of Cancer Cell Biology of the 1st Faculty of Medicine and the Institute of Physiology of Academy of Sciences of Czech Republic. Next 15 years he was associated with the 1st Faculty of Medicine, Charles University in Prague, where currently he is Vice-dean and Professor of Biochemistry, Head of the Institute of Biochemistry and Experimental Oncology and Member of Scientific Board. Prof Šedo is also a Head-Founder of Czech Society for Neuro-Oncology of Czech Oncology Society, Member of Scientific Board of Czech Science Foundation, Member of Scientific Board of Masaryk Memorial Cancer Institute, Member of Czech Medical Academy (FCMA).
He is investigator of numerous national and international grant projects, co-investigator of several international projects and member of the Executive board of EATRIS-cz consortium, Operational Programme RDE Ministry of Education, Youths and Sports project “Centre of Cancer Ecology” etc. Since 2018, prof. Šedo leads the 4EU+ Czech program coordinator: Comprehensive and integrative educational program in oncology.